Form 8-K ChemoCentryx, Inc. For: May 21

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 21, 2015

 

 

CHEMOCENTRYX, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-35420		94-3254365
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

850 Maude Avenue, Mountain View, CA		94043
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (650) 210-2900

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.07. Submission of Matters to a Vote of Security Holders

ChemoCentryx, Inc. (the “Company”) held its annual meeting of stockholders on May 21, 2015. The following is a brief description of each matter voted upon at the meeting and the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.

 

1.

To elect the following directors for a three-year term to expire at the 2018 annual meeting of stockholders:

 

Director Name		For				Withheld				Broker Non-Votes
Thomas J. Schall, Ph.D.			29,525,651				71,180				3,428,112
Joseph M. Feczko, M.D.			29,525,906				70,925				3,428,112

In accordance with the above results, above nominees were elected to serve as directors.

 

2.

To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015:

 

For		Against		Abstain		Broker Non-Votes
32,946,525		65,499		12,919		0

In accordance with the above results, the selection of Ernst and Young LLP was approved.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

				CHEMOCENTRYX, INC.
Date: May 22, 2015
				By:		/s/ Susan M. Kanaya
				Name:		Susan M. Kanaya
				Title:		Senior Vice President, Finance, Chief Financial Officer and Secretary

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Robin Hunden of Hunden Partners Honored With Jeffrey D. Fisher Real Estate Legacy Award From Indiana University’s Kelley School of Business
• Xcite Automotive Enhances Dealership Service Offerings with Strategic Acquisition of Pinnacle Automotive and Adds Two Board Members
• Ace Hardware Introduces Vintage Threads™ Apparel